Sakai Yu, Yoshikawa Gakushi, Koizumi Satoshi, Ishikawa Osamu, Saito Akira, Sato Katsuya
Department of Neurosurgery, Showa General Hospital, Kodaira, Tokyo, Japan.
Department of Neurosurgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
J Neuroendovasc Ther. 2023;17(1):15-21. doi: 10.5797/jnet.oa.2022-0057. Epub 2022 Nov 29.
There are insufficient coherent reports on mechanical thrombectomy (MT) for occlusion of the second segment of the middle cerebral artery (M2 occlusion) in a real-world clinical setting. We evaluated the efficacy and safety of MT for M2 occlusions and compared the primary thrombectomy strategies (stent retriever, aspiration catheter, and combined technique) to analyze factors predicting good functional outcomes.
We evaluated background factors, preprocedural factors, procedural factors, and procedural time for patients who underwent MT for M2 occlusions from our retrospective cohort. According to the modified Rankin Scale (mRS) score three months after MT, patients were divided into good (mRS ≤2) and poor (mRS ≥3) prognosis groups.
A total of 29 patients (median age, 78 years; 11 [37.9%] females) were included in the study. In this cohort, rates of successful reperfusion, thrombolysis in cerebral infarction (TICI) 3, postprocedural hemorrhage (PPH), and symptomatic PPH were 82.8, 34.5, 31.0, and 0%, respectively. Good prognoses were achieved in 13 (45%) cases. A prognostic factor of MT for M2 occlusions is TICI 3 from multivariate analysis (OR, 11.7; 95% CI, 1.003-136; p = 0.0497). There was no statistically significant difference in the functional outcome three months after MT based on the choice of the primary thrombectomy strategy.
MT for M2 occlusions is a reliable and relatively safe procedure. The presence of TICI 3 was a prognostic factor in this cohort. Future studies are warranted to investigate the optimal thrombectomy strategy for medium vessel occlusion.
在真实临床环境中,关于大脑中动脉第二段闭塞(M2闭塞)的机械取栓术(MT),目前缺乏连贯的报道。我们评估了MT治疗M2闭塞的有效性和安全性,并比较了主要的取栓策略(支架取栓器、抽吸导管和联合技术),以分析预测良好功能结局的因素。
我们对回顾性队列中接受MT治疗M2闭塞的患者的背景因素、术前因素、手术因素和手术时间进行了评估。根据MT术后三个月的改良Rankin量表(mRS)评分,将患者分为预后良好(mRS≤2)和预后不良(mRS≥3)两组。
本研究共纳入29例患者(中位年龄78岁;11例[37.9%]为女性)。在该队列中,成功再灌注率、脑梗死溶栓(TICI)3级、术后出血(PPH)和有症状PPH的发生率分别为82.8%、34.5%、31.0%和0%。13例(45%)患者预后良好。多因素分析显示,MT治疗M2闭塞的一个预后因素是TICI 3级(OR,11.7;95%CI,1.003 - 136;p = 0.0497)。基于主要取栓策略的选择,MT术后三个月的功能结局无统计学显著差异。
MT治疗M2闭塞是一种可靠且相对安全的手术。TICI 3级的存在是该队列中的一个预后因素。未来有必要开展研究,以探讨中血管闭塞的最佳取栓策略。